Celcuity (CELC) Debt Ratio (2021 - 2025)
Celcuity (CELC) reported Debt Ratio of 0.27 for Q4 2025, down 31.98% on a YoY basis from 0.4 in Q4 2024, and up 3.13% quarter-over-quarter from 0.26 in Q3 2025.
Celcuity (CELC) Debt Ratio (2021 - 2025) Analysis & Trends
Celcuity has reported Debt Ratio for 5 years, with the latest figure at 0.27 in Q4 2025.
- For the quarter ending Q4 2025, Debt Ratio fell 31.98% year-over-year to 0.27; the trailing twelve-month figure through Dec 2025 stood at 0.27 (down 31.98% YoY), and the FY2025 full-year result was 0.27, down 31.98% from the prior year.
- Debt Ratio for Q4 2025 stood at 0.27, up from 0.26 in the prior quarter.
- The five-year high for Debt Ratio was 0.54 in Q2 2025, with the low at 0.16 in Q3 2021.
- Historically, Debt Ratio has averaged 0.27 across 5 years, with a median of 0.23 in 2023.
- Annual changes were most pronounced in 2022 — Debt Ratio sank 37.59% — and 2025, when it soared 126.27%.
- Celcuity's Debt Ratio stood at 0.17 in 2021, then rose by 16.95% to 0.2 in 2022, then declined by 2.73% to 0.19 in 2023, then soared by 105.85% to 0.4 in 2024, then slumped by 31.98% to 0.27 in 2025.
- The last three Debt Ratio figures came in at 0.27 (Q4 2025), 0.26 (Q3 2025), and 0.54 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 0.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.26 |
| Jun 30, 2025 | 0.54 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.20 |
| Dec 31, 2023 | 0.19 |
| Sep 30, 2023 | 0.26 |
| Jun 30, 2023 | 0.23 |
| Mar 31, 2023 | 0.22 |
| Dec 31, 2022 | 0.20 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 0.19 |
| Dec 31, 2021 | 0.17 |
| Sep 30, 2021 | 0.16 |
| Jun 30, 2021 | 0.33 |